Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Norovirus”

57 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 57 results

Early research (Phase 1)Study completedNCT04188691
What this trial is testing

A Clinical Trial to Evaluate the Safety and Immunogenicity of Norovirus Bivalent Vaccine

Who this might be right for
Norwalk GastroenteritisNorovirus Infections
National Vaccine and Serum Institute, China 510
Early research (Phase 1)Study completedNCT03125473
What this trial is testing

Dose-Optimization Trial of VXA-G1.1-NN in Healthy Volunteers

Who this might be right for
Norovirus Gastroenteritis
Vaxart 66
Testing effectiveness (Phase 2)UnknownNCT04941261
What this trial is testing

Clinical Trial to Evaluate the Recombinant Norovirus Bivalent (GI. 1 / GII. 4) Vaccine (Hansenula Polymorpha)

Who this might be right for
Norovirus InfectionsNorwalk Gastroenteritis
National Vaccine and Serum Institute, China 1,716
Early research (Phase 1)Active Not RecruitingNCT06944717
What this trial is testing

A Trial of a Norovirus G1.1 and G2.4 Vaccine Administered Orally to Healthy Participants Aged ≥ 18 Years and ≤ 80 Years Old

Who this might be right for
Norovirus Infections
Vaxart 60
Early research (Phase 1)Study completedNCT06007781
What this trial is testing

Safety and Immunogenicity of HIL-214 in Healthy Japanese Infants

Who this might be right for
Gastroenteritis
HilleVax 21
Large-scale testing (Phase 3)Active Not RecruitingNCT06524947
What this trial is testing

Clinical Trial of Protective Efficacy of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris)

Who this might be right for
Acute Gastroenteropathy Due to Norovirus
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 6,600
Testing effectiveness (Phase 2)Study completedNCT00656084
What this trial is testing

Ph2 Gem/Nov/Rituxan Rel/Ref MantleCell

Who this might be right for
Relapsed or Refractory Mantle Cell Lymphoma (MCL)
US Oncology Research 16
Early research (Phase 1)Study completedNCT00806962
What this trial is testing

Phase 1 Norwalk Vaccine Study

Who this might be right for
Norovirus
LigoCyte Pharmaceuticals, Inc. 61
Early research (Phase 1)Study completedNCT07254728
What this trial is testing

Evaluate Vaxart's Oral Bivalent GI.1/GII.4 Norovirus Vaccine in Healthy Lactating Females and Their Nursing Infants

Who this might be right for
Norovirus Infections
Vaxart 76
Early research (Phase 1)Study completedNCT01435811
What this trial is testing

Dose Range Evaluation of Norovirus Challenge Pool (GII.4, CIN-1)

Who this might be right for
Norovirus Infections
Children's Hospital Medical Center, Cincinnati 60
Not applicableStudy completedNCT03981198
What this trial is testing

Proof of Concept (POC) Study of the Soliton Rapid Acoustic (RAP) for the Treatment of Cellulite

Who this might be right for
Cellulite
Soliton 10
Early research (Phase 1)Study completedNCT05213728
What this trial is testing

A Phase 1, Open-label, Safety and Immunogenicity Study of an Oral Multi-dose Administration Regimen With an Adenoviral-vector Based Tablet Norovirus Vaccine (VXA-G1.1-NN) Administered to Healthy Adult Volunteers

Who this might be right for
Norovirus Infections
Vaxart 8
Early research (Phase 1)Study completedNCT03721549
What this trial is testing

Evaluation of Infectivity and Illness of Norwalk GI.1 Virus Lot 001-09NV in the Human Challenge Model

Who this might be right for
Norovirus Infection
WCCT Global 16
Testing effectiveness (Phase 2)Study completedNCT02142504
What this trial is testing

Safety and Immunogenicity of Norovirus Bivalent Virus-Like Particle Vaccine in Healthy Adults

Who this might be right for
Norovirus Prevention
Takeda 454
Early research (Phase 1)WithdrawnNCT02337842
What this trial is testing

Phase I Study to Determine the Optimal Human Challenge Dose for a Norovirus GII.4 Challenge Stock (CIN-1)

Who this might be right for
Gastroenteritis Norovirus
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT02669121
What this trial is testing

Efficacy and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in Adults

Who this might be right for
Healthy Volunteers
Takeda 4,748
Not applicableLooking for participantsNCT01306084
What this trial is testing

Viral Infections in Healthy and Immunocompromised Hosts

Who this might be right for
Anogenital HerpesCOVID-19Herpes Labialis
National Institute of Allergy and Infectious Diseases (NIAID) 1,000
Not applicableStudy completedNCT00674336
What this trial is testing

Infectivity of Norovirus in Shellfish Treated With High Hydrostatic Pressure Processing-Human Challenge Study

Who this might be right for
Healthy
Emory University 51
Testing effectiveness (Phase 2)Study completedNCT02038907
What this trial is testing

Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent VLP Vaccine

Who this might be right for
Healthy VolunteersNorovirus, Prevention
Takeda 420
Early research (Phase 1)Study completedNCT01322503
What this trial is testing

Susceptibility of Human Volunteers With Different Histo-Blood With Different Histo-Blood Group Antigens to Norovirus

Who this might be right for
Healthy Adults
Children's Hospital Medical Center, Cincinnati 40
Load More Results